The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma

American Journal of Surgery

Volumn 199, Issue 4, 2010, Pages 447-452

  Kawai, Manabu ^a   Tani, Masaji ^a   Kobayashi, Yasuhito ^a   Tsuji, Takeshi ^a   Tabuse, Katsuyoshi ^a   Horiuchi, Tetsuya ^a   Oka, Masami ^a   Yamaguchi, Kazuya ^a   Sakata, Yoshifumi ^a   Shimomura, Tomoo ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Lymph node metastasis; Overall survival; Pancreaticoduodenectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PERINEUM; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME;

ACTUARIAL ANALYSIS; ADULT; AGED; AXILLA; BILE DUCT NEOPLASMS; BILIARY TRACT SURGICAL PROCEDURES; CARCINOMA; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 77949876546     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.01.019     Document Type: Article

References (27)

1. Jang J.Y., Kim S.W., Park D.J., et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 241 (2005) 77-84
2. Kayahara M., Nagakawa T., Ohta T., et al. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 229 (1999) 76-83
3. Sakamoto Y., Kosuge T., Shimada K., et al. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 137 (2005) 396-402
4. Todoroki T., Kawamoto T., Koike N., et al. Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg 88 (2001) 364-370
5. DeOliveira M.L., Cunningham S.C., Cameron J.L., et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245 (2007) 755-762
6. Woo S.M., Ryu J.K., Lee S.H., et al. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 14 (2007) 3195-3201
7. Blom D., and Schwartz S.I. Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts: the University of Rochester experience. Arch Surg 136 (2001) 209-215
8. Cheng Q., Luo X., Zhang B., et al. Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol 14 (2007) 1212-1219
9. Sasaki R., Takahashi M., Funato O., et al. Prognostic significance of lymph node involvement in middle and distal bile duct cancer. Surgery 129 (2001) 677-683
10. Hong S.M., Cho H., Lee O.J., et al. The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor. Am J Surg Pathol 29 (2005) 1177-1183
11. Murakami Y., Uemura K., Hayashidani Y., et al. Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg 31 (2007) 337-342
12. Yoshida T., Matsumoto T., Sasaki A., et al. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 137 (2002) 69-73
13. Wakai T., Shirai Y., Moroda T., et al. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 103 (2005) 1210-1216
14. Ebata T., Watanabe H., Ajioka Y., et al. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 89 (2002) 1260-1267
15. Hong S.M., Kim M.J., Pi D.Y., et al. Analysis of extrahepatic bile duct carcinomas according to the new American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients. Cancer 104 (2005) 802-810
16. Hernandez J., Cowgill S.M., Al-Saadi S., et al. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection. Ann Surg Oncol 15 (2008) 807-814
17. Mariette C., Piessen G., Briez N., et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247 (2008) 365-371
18. Nitti D., Marchet A., Olivieri M., et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10 (2003) 1077-1085
19. Marchet A., Mocellin S., Ambrosi A., et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 245 (2007) 543-552
20. Berger A.C., Sigurdson E.R., LeVoyer T., et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23 (2005) 8706-8712
21. Le Voyer T.E., Sigurdson E.R., Hanlon A.L., et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21 (2003) 2912-2919
22. Pawlik T.M., Gleisner A.L., Cameron J.L., et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141 (2007) 610-618
23. Berger A.C., Watson J.C., Ross E.A., et al. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70 (2004) 235-240
24. Falconi M., Crippa S., Dominguez I., et al. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. Ann Surg Oncol 15 (2008) 3178-3186
25. Greene F.L. TNM staging for malignancies of the digestive tract: 2003 changes and beyond. Semin Surg Oncol 21 (2003) 23-29
26. Kelley S.T., Bloomston M., Serafini F., et al. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy. Am Surg 70 (2004) 743-748
27. Smeenk H.G., van Eijck C.H., Hop W.C., et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40,891. Ann Surg 246 (2007) 734-740